Transfection of the BDNF Gene in the Surviving Dopamine Neurons in Conjunction with Continuous Administration of Pramipexole Restores Normal Motor Behavior in a Bilateral Rat Model of Parkinson's Disease

Alina Benítez-Castañeda,Verónica Anaya-Martínez,Armando de Jesús Espadas-Alvarez,Ana Luisa Gutierrez-Váldez,Luis Fernando Razgado-Hernández,Patricia Emmanuelle Reyna-Velazquez,Liz Quintero-Macias,Daniel Martínez-Fong,Benjamín Florán-Garduño,Jorge Aceves

DOI: https://doi.org/10.1155/2024/3885451

2024-02-22

Parkinson s Disease

Abstract:In Parkinson's disease (PD), progressive degeneration of nigrostriatal innervation leads to atrophy and loss of dendritic spines of striatal medium spiny neurons (MSNs). The loss disrupts corticostriatal transmission, impairs motor behavior, and produces nonmotor symptoms. Nigral neurons express brain-derived neurotropic factor (BDNF) and dopamine D3 receptors, both protecting the dopamine neurons and the spines of MSNs. To restore motor and nonmotor symptoms to normality, we assessed a combined therapy in a bilateral rat Parkinson's model, with only 30% of surviving neurons. The preferential D3 agonist pramipexole (PPX) was infused for four 1⁄2 months via mini-osmotic pumps and one month after PPX initiation; the BDNF-gene was transfected into the surviving nigral cells using the nonviral transfection NTS-polyplex vector. Overexpression of the BDNF-gene associated with continuous PPX infusion restored motor coordination, balance, normal gait, and working memory. Recovery was also related to the restoration of the average number of dendritic spines of the striatal projection neurons and the number of TH-positive neurons of the substantia nigra and ventral tegmental area. These positive results could pave the way for further clinical research into this promising therapy.

clinical neurology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to restore normal motor behaviors and non - motor symptoms through combination therapy in Parkinson's Disease (PD). Specifically, the researchers evaluated the effect of a combined therapy in bilateral rat models of Parkinson's disease, in which only 30% of dopaminergic neurons remained. The combined therapy includes:

1. **Pramipexole (PPX)**: This is a selective dopamine D3 receptor agonist, which is continuously administered via a mini - osmotic pump for four and a half months.
2. **BDNF gene transfection**: One month after PPX administration, the BDNF gene is transfected into the surviving substantia nigra cells using a non - viral transfected NTS - polyplex vector.

The main objectives of the study were to evaluate whether this combined therapy could:
- Restore motor coordination, balance, normal gait, and working memory.
- Restore the number of dendritic spines of striatal projection neurons.
- Restore the number of tyrosine hydroxylase - positive (TH - positive) neurons in the Substantia Nigra pars Compacta (SNc) and Ventral Tegmental Area (VTA).

### Main findings
1. **Recovery of balance and motor coordination**:
- The impaired rats significantly increased the time to cross the beam in the beam - walking test, and some rats could not even complete it within 2 minutes. However, the combined treatment completely restored the beam - crossing time, and the restored performance was not significantly different from that of normal rats.
- The rotarod test also showed that the impaired rats could not stay on the rotarod at low - speed rotation. The combined treatment completely restored the motor coordination ability on the rotarod.

2. **Normalization of gait**:
- Bilateral lesions led to a shortening of step length (about 40%) and a slowing of speed (about 40%). The combined treatment significantly improved the step length and speed, restoring them to normal levels.
- The ankle joint angle was also restored, indicating a comprehensive improvement in gait parameters.

3. **Recovery of working memory**:
- Dopamine depletion reduced the object recognition index (ORI) by 78%. The combined treatment completely restored the ORI to the level of normal rats.
- In terms of exploratory behavior, the combined treatment failed to restore the standing frequency and spontaneous activity of the impaired rats.

4. **Recovery of TH - positive neurons**:
- 6 - OHDA lesions significantly reduced the number of TH - positive neurons in SNc and VTA, by 65 - 68% and 68 - 70% respectively. The combined treatment completely restored the number of TH - positive neurons in these areas.

5. **Recovery of dendritic spines**:
- Bilateral lesions significantly reduced the number of dendritic spines of MSN, by 42% on the right side and 35% on the left side. The combined treatment restored the number of these dendritic spines.

These results indicate that the combined treatment has a significant effect on restoring motor and non - motor symptoms in rat models of Parkinson's disease, providing hope for further clinical research.